ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 410 filers reported holding ENCOMPASS HEALTH CORP in Q3 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,214,794 | +54.7% | 32,710 | +23.6% | 1.93% | +162.8% |
| Q1 2023 | $1,432,081 | -69.4% | 26,471 | -66.1% | 0.74% | -61.2% |
| Q4 2022 | $4,673,793 | +24.6% | 78,144 | -5.8% | 1.90% | +55.3% |
| Q3 2022 | $3,751,000 | -19.7% | 82,929 | +26.3% | 1.22% | -0.7% |
| Q1 2022 | $4,669,000 | -57.4% | 65,653 | -50.9% | 1.23% | -56.9% |
| Q1 2021 | $10,958,000 | +81.3% | 133,801 | +83.0% | 2.86% | +31.1% |
| Q4 2020 | $6,045,000 | -66.3% | 73,104 | -73.5% | 2.18% | -58.9% |
| Q3 2020 | $17,941,000 | +105.2% | 276,105 | +95.5% | 5.31% | +1007.7% |
| Q2 2020 | $8,744,000 | +145.5% | 141,195 | +153.9% | 0.48% | -70.3% |
| Q1 2020 | $3,561,000 | -68.5% | 55,614 | -65.9% | 1.61% | -54.7% |
| Q4 2019 | $11,297,000 | +1400.3% | 163,092 | +1271.4% | 3.56% | +1218.1% |
| Q3 2019 | $753,000 | -89.6% | 11,892 | -89.6% | 0.27% | -90.6% |
| Q2 2019 | $7,274,000 | +38.3% | 114,801 | +34.6% | 2.87% | +3.1% |
| Q4 2018 | $5,261,000 | – | 85,272 | – | 2.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |